Hagar Andrew D, Fang Christopher J, Dannenbaum Joseph H, Smith Eric L, Bono James V, Talmo Carl T
Department of Orthopaedic Surgery, Tufts University School of Medicine, Boston, MA.
Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA.
J Arthroplasty. 2022 May;37(5):851-856. doi: 10.1016/j.arth.2022.01.026. Epub 2022 Jan 19.
Periarticular injections (PAIs) and adductor canal blocks (ACBs) are widely accepted pain management strategies for total knee arthroplasty (TKA); however, the optimal anesthetic concentration to provide adequate pain relief while avoiding toxicity remains controversial. The purpose of this study is to evaluate the efficacy of different anesthetic concentrations for PAI alone and in combination with ACB.
This retrospective cohort study of patients undergoing primary TKAs between January 2019 and November 2020 included 3 groups: 0.25% PAI (50 cc of 0.25% bupivacaine PAI diluted with 50 cc of saline and ketorolac), 0.5% PAI (50 cc of 0.5% bupivacaine with 50 cc of saline and ketorolac), and PAI + ACB (ultrasound-guided preoperative anesthesiologist-administered ACB and 0.25% PAI).
In total, 368 TKAs were analyzed (123 0.25%, 132 0.5%, and 113 PAI + ACB). Total overall hospital narcotic usage in oral morphine equivalents (OME) was significantly lower for the 0.5% group (120.09 vs 165.26 and 175.75) compared to the 0.25% and PAI + ACB groups, respectively (P < .0001). Cumulative OME for the first 3 shifts was also lower for 0.5% (68.7 vs 83.7 and 76.4) compared to the 0.25% and PAI + ACB groups, respectively (P = .030). Total postoperative narcotics in OME were significantly lower for 0.5% (617.9 vs 825.2 and 1047.6) than 0.25% and PAI + ACB, respectively (P = .0003). Number of prescriptions within 6 weeks postoperatively were also significantly lower for 0.5% (1.7) than 0.25% (2.1) and PAI + ACB (2.4) (P = .0003).
Patients receiving 0.5% PAI had lower narcotic usage compared to 0.25% PAI or PAI + ACB. ACB may be eliminated without compromising pain control if the dose of local anesthetic in the PAI is sufficiently high.
关节周围注射(PAIs)和内收肌管阻滞(ACBs)是全膝关节置换术(TKA)广泛接受的疼痛管理策略;然而,在避免毒性的同时提供充分疼痛缓解的最佳麻醉浓度仍存在争议。本研究的目的是评估单独使用PAI以及PAI与ACB联合使用时不同麻醉浓度的疗效。
这项对2019年1月至2020年11月期间接受初次TKA的患者进行的回顾性队列研究包括3组:0.25%PAI组(50毫升0.25%布比卡因PAI用50毫升生理盐水和酮咯酸稀释)、0.5%PAI组(50毫升0.5%布比卡因加50毫升生理盐水和酮咯酸)以及PAI+ACB组(术前由麻醉医生在超声引导下实施ACB并联合0.25%PAI)。
总共分析了368例TKA(123例为0.25%组,132例为0.5%组,113例为PAI+ACB组)。与0.25%组和PAI+ACB组相比,0.5%组以口服吗啡当量(OME)计算的总住院麻醉药物使用量显著更低(分别为120.09 vs 165.26和175.75)(P<.0001)。与0.25%组和PAI+ACB组相比,0.5%组前3个班次的累积OME也更低(分别为68.7 vs 83.7和76.4)(P=.030)。以OME计算的术后总麻醉药物使用量,0.5%组(617.9 vs 825.2和1047.6)显著低于0.25%组和PAI+ACB组(P=.0003)。术后6周内的处方数量,0.5%组(1.7)也显著低于0.25%组(2.1)和PAI+ACB组(2.4)(P=.0003)。
与0.25%PAI或PAI+ACB相比,接受0.5%PAI的患者麻醉药物使用量更低。如果PAI中局部麻醉剂的剂量足够高,则可以在不影响疼痛控制的情况下不进行ACB。